Through its pharmaceutical and vaccine agencies, Litha Healthcare Group strives to consistently provide products which conform to the very highest Regulatory and current Good Manufacturing Practices (cGMPs) requirements.

These objectives are achieved through the implementation and maintenance of a comprehensive Quality Management System based on ISO 9002 and consistent with cGMP which defines a state of control which ensures continuous production of high quality products.

By building on quality and service at every stage, Litha Healthcare Group are able to implement and maintain a Quality Management System (QMS) which:

• Promotes excellence
• Instils a ‘right first time’ attitude
• Supports an organisation of learning, and
• Ensures everyone understands their quality-related requirements and responsibilities

All Litha Healthcare Group Limited subsidiary companies comply with the South Africa current Good Manufacturing Practise Guideline (cGMPs), which are aligned with the standards set by the Pharmaceutical International Convention/Pharmaceutical Inspection Co-operation Scheme (PIC/S).

Through its subsidiaries, Litha Healthcare Group is a member of the National Association of Pharmaceutical Manufacturers (NAPM), Self Medication Association of South Africa (SMASA), South African Medical Device Industry Association (SAMED) and Pharmaceuticals Made in South Africa (PHARMISA).

Litha Vaccines is currently in the process of obtaining ISO 9001 certification and The Biovac Institute sources and supplies products which are pre-qualified by the WHO (World Health Organisation).